The Latest Breaking News from PFE

This Dividend Stock Yields Nearly 8% and Trades at Depressed Valuations: Time to Buy?

Amid the continued decline in Pfizer stock, its dividend yield has risen to almost 8%. While the stock might not be a screaming buy, it now seems to have limited downside.

Barchart · Apr 17, 2025

What You Need to Know Ahead of Pfizer's Earnings Release

Pfizer will release its first-quarter earnings later this month, and analysts anticipate a double-digit profit dip.

Barchart · Apr 16, 2025

Huge Unusual Trading in Pfizer Put Options Signals Investors' Bearish Outlook

Large, unusual trading volume in Pfizer put options is accruing today, signaling a bearish outlook by institutional investors in PFE stock. This undoubtedly relates to the Chinese tariffs, and investors' concerns.

Barchart · Apr 9, 2025

Stock Index Futures Muted Ahead of U.S. JOLTs Report and Fed Speak, Alphabet Earnings on Tap

March S&P 500 E-Mini futures (ESH25) are down -0.01%, and March Nasdaq 100 E-Mini futures (NQH25) are up +0.08% this morning as investors awaited the latest reading on U.S. job openings, comments from Federal Reserve officials, and corporate earnings reports from heavyweight names.

Barchart · Feb 4, 2025

Pfizer Stock Outlook: Is Wall Street Bullish or Bearish?

Despite Pfizer trailing behind the broader market over the past year, Wall Street analysts remain moderately bullish about the stock's potential.

Barchart · Jan 30, 2025

This Dividend Stock Has Plunged Ahead of Trump’s Inauguration. Here Are 3 Reasons Investors Should Still Buy It.

For savvy investors, Pfizer could be an undervalued stock to buy here.

Barchart · Jan 16, 2025

3 Pharmaceutical Stocks Addressing Global Health Challenges

With the recent rise of diseases, pharmaceutical companies are pushing boundaries in medicine, from life-saving treatments to pioneering global healthcare solutions. Hence, investing in established pharmaceutical stocks, Pfizer (PFE), Johnson & Johnson (JNJ), and Merck & Co. (MRK) presents a compelling opportunity to capitalize for the long term. Read more.

StockNews.com · Jan 13, 2025

What to Expect From Pfizer's Next Quarterly Earnings Report

Pfizer is poised to announce its fourth-quarter results next month, and analysts predict a significant growth in the company’s bottom-line figure.

Barchart · Jan 10, 2025

Pfizer: 4 Reasons to Buy This Stock

Pharmaceutical giant Pfizer Inc. (NYSE: PFE) stock is trading back down near its pandemic lows. Every time it attempts to climb over the $30 mark, something ca

MarketBeat · Dec 31, 2024

3 High-Yield Dividend Stocks to Secure Before Year-End

Dividend-paying stocks provide investors with consistent income in turbulent markets, especially as payouts grow over time. Therefore, investors might consider adding dividend stocks, Pfizer (PFE), United Parcel Service (UPS), and Enterprise Products Partners (EPD) before year-end. Read more….

StockNews.com · Dec 18, 2024